Oralee J. Varnado

Similar efficacy and safety of once‐weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years

Malaz Boustani, Isabella Pittman, Miao Yu et al. · Diabetes Obesity and Metabolism · 2016 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial

Todd J. Schwedt, Tina M. Oakes, James M. Martinez et al. · Neurology and Therapy · 2023 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey

Jingwen Liu, Jeoffrey Bispham, Ludi Fan et al. · BMJ Open · 2020 · 28 citations · Full text

Social Sciences, Health Behavior, Psychology +17

Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study

Oralee J. Varnado, Janna Manjelievskaia, Wenyu Ye et al. · Dove Medical Press (Taylor and Francis Group) · 2022 · 28 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Patient‐reported outcome results in patients with type 2 diabetes treated with once‐weekly dulaglutide: data from the <scp>AWARD</scp> phase <scp>III</scp> clinical trial programme

Miao Yu, Kate Van Brunt, Oralee J. Varnado et al. · Diabetes Obesity and Metabolism · 2015 · 27 citations

Pharmacy, Endocrinology, Internal Medicine +17